[VIEW] agent=Oncology Nursing Director (Infusion Center) | scenario_id=116 | rounds=20

--- Round 0 ---
[R0.1] Pharmacy Compliance & Infusion Services Manager (speak, public): To make an informed decision about the expansion of outpatient oncology infusion access, I need to gather some crucial information. Can you provide insights on the projected demand for infusion services, as well as any changes in staffing shifts you anticipate? Additionally, what do you see as the financial threshold for sustainability in this expansion?
[R0.2] Oncology Nursing Director (Infusion Center) (speak, private to=Pharmacy Compliance & Infusion Services Manager): The projected demand for infusion services indicates we are seeing an average of 18 new referrals per week. Additionally, our current chair utilization baseline is at 92% during peak hours. Regarding staffing, we predict that extending hours will necessitate approximately 1.6 RN FTEs. I believe these factors will contribute significantly to our sustainability analysis. However, I need to confirm the medication prep capacity and understand any compliance constraints that may affect this expansion. Can you provide insights on those aspects?
[R0.3] Health System Finance & Strategy Manager (speak, private to=Pharmacy Compliance & Infusion Services Manager,Oncology Nursing Director (Infusion Center)): To assess the financial sustainability of the expansion, we have an FY26 infusion expansion capex set at $250,000, with a net revenue of $620 per infusion visit. The incremental operating cost is estimated at $310,000 per year, and we need to achieve a break-even point of 14 additional visits per day to ensure viability. However, I need more information on projected demand and any changes in staffing shifts that you anticipate to complete the financial analysis. Could you provide that?

--- Round 1 ---
[R1.1] Pharmacy Compliance & Infusion Services Manager (speak, public): In response to your inquiries, I can confirm that our IV room staffing baseline is set at 2 pharmacy technicians per weekday shift, which aligns with the anticipated increase in demands. Additionally, we adhere to the USP <797> beyond-use dating policy, allowing for medium-risk compounded sterile preparations with a BUD of 9 days refrigerated. Regarding hazardous drug handling, we utilize closed-system transfer devices for two drug classes, ensuring safety and compliance. With these factors in mind, we can better evaluate the operational feasibility of the expansion. Are there any indications of workforce fragility or reimbursement challenges that we should be aware of?
[R1.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R1.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 2 ---
[R2.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R2.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R2.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 3 ---
[R3.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R3.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R3.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 4 ---
[R4.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R4.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R4.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 5 ---
[R5.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R5.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R5.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 6 ---
[R6.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R6.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R6.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 7 ---
[R7.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R7.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R7.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 8 ---
[R8.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R8.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R8.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 9 ---
[R9.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R9.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R9.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 10 ---
[R10.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R10.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R10.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 11 ---
[R11.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R11.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R11.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 12 ---
[R12.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R12.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R12.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 13 ---
[R13.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R13.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R13.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 14 ---
[R14.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R14.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R14.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 15 ---
[R15.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R15.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R15.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 16 ---
[R16.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R16.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R16.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 17 ---
[R17.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R17.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R17.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 18 ---
[R18.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R18.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R18.3] Health System Finance & Strategy Manager (leave, public): 

--- Round 19 ---
[R19.1] Pharmacy Compliance & Infusion Services Manager (leave, public): 
[R19.2] Oncology Nursing Director (Infusion Center) (leave, public): 
[R19.3] Health System Finance & Strategy Manager (leave, public): 

